ZA201803649B - Attenuated influenza vectors for the prevention and/or treatment of infectious diseases and for the treatment of oncological diseases - Google Patents
Attenuated influenza vectors for the prevention and/or treatment of infectious diseases and for the treatment of oncological diseasesInfo
- Publication number
- ZA201803649B ZA201803649B ZA201803649A ZA201803649A ZA201803649B ZA 201803649 B ZA201803649 B ZA 201803649B ZA 201803649 A ZA201803649 A ZA 201803649A ZA 201803649 A ZA201803649 A ZA 201803649A ZA 201803649 B ZA201803649 B ZA 201803649B
- Authority
- ZA
- South Africa
- Prior art keywords
- treatment
- diseases
- prevention
- attenuated influenza
- oncological
- Prior art date
Links
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2015147703A RU2628690C2 (en) | 2015-11-06 | 2015-11-06 | Attenuated influenza vectors for the prevention and/or treatment of infectious diseases, as well as for cancer treatment |
RU2016111907A RU2660562C2 (en) | 2016-03-30 | 2016-03-30 | Attenuated grippose vector and mucosal universal grippose vaccine on its basis |
PCT/RU2016/050066 WO2017078577A2 (en) | 2015-11-06 | 2016-11-03 | Attenuated influenza vectors for the prevention and/or treatment of infectious diseases and for the treatment of oncological diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA201803649B true ZA201803649B (en) | 2019-11-27 |
Family
ID=62748489
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA201803649A ZA201803649B (en) | 2015-11-06 | 2018-05-31 | Attenuated influenza vectors for the prevention and/or treatment of infectious diseases and for the treatment of oncological diseases |
Country Status (3)
Country | Link |
---|---|
CL (1) | CL2018001201A1 (en) |
EA (1) | EA037571B1 (en) |
ZA (1) | ZA201803649B (en) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU771110B2 (en) * | 1998-06-12 | 2004-03-11 | Mount Sinai School Of Medicine Of The City University Of New York, The | Novel methods and interferon deficient substrates for the propagation of viruses |
US6800288B2 (en) * | 2000-03-02 | 2004-10-05 | Polymun Scientific Immunbiologische Forschung Gmbh | Recombinant influenza A viruses |
US7037707B2 (en) * | 2003-09-04 | 2006-05-02 | St. Jude Children's Research Hospital | Method for generating influenza viruses and vaccines |
-
2016
- 2016-11-03 EA EA201792083A patent/EA037571B1/en unknown
-
2018
- 2018-05-03 CL CL2018001201A patent/CL2018001201A1/en unknown
- 2018-05-31 ZA ZA201803649A patent/ZA201803649B/en unknown
Also Published As
Publication number | Publication date |
---|---|
EA201792083A1 (en) | 2018-07-31 |
EA037571B1 (en) | 2021-04-15 |
CL2018001201A1 (en) | 2018-09-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1251554A1 (en) | Novel substituted aminothiazolopyrimidinedione for the treatment and prophylaxis of virus infection | |
HK1248711A1 (en) | Novel substituted aminothiazolopyrimidinedione for the treatment and prophylaxis of virus infection | |
IL263972A (en) | Dihydropyranopyrimidines for the treatment of viral infections | |
HK1251616A1 (en) | Attenuated influenza vectors for the prevention and/or treatment of infectious diseases and for the treatment of oncological diseases | |
HK1223931A1 (en) | Novel dihydroquinolizinones for the treatment and prophylaxis of hepatitis b virus infection | |
IL246449B (en) | 6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection | |
ZA201705633B (en) | A new quinoline derivative for use in the treatment and prevention of viral infections | |
ZA201705634B (en) | Quinoline derivatives for use in the treatment or prevention of viral infection | |
HK1231402A1 (en) | Methods for the treatment of hepatitis b and hepatitis d virus infections b d | |
IL263368A (en) | Prevention and treatment of viral infections | |
GB201611712D0 (en) | Methods and compounds for the treatment or prevention of severe or persistent influenza | |
HK1252343A1 (en) | Compositions and methods for the treatment of viral infection | |
PL3183003T3 (en) | Methods for prevention and/or treatment of infection | |
SI3197556T1 (en) | Composition for the prevention and/or treatment of allergy symptoms | |
GB201615035D0 (en) | Treatment and prevention of viral infection | |
PL3095866T3 (en) | Agent for the prophylaxis and therapy of viral infections | |
ZA201803649B (en) | Attenuated influenza vectors for the prevention and/or treatment of infectious diseases and for the treatment of oncological diseases | |
EP3490604C0 (en) | Medicament for the treatment and/or prevention of endometriosis | |
SG11201705889VA (en) | Prevention or Treatment of Uratic or Gouty Diseases | |
GB201520019D0 (en) | The genome and self-evolution of AI | |
GB201522828D0 (en) | Prevention and treatment of glaucoma |